Literature DB >> 24788224

ApoE-deficient promotes blood-brain barrier disruption in experimental autoimmune encephalomyelitis via alteration of MMP-9.

Minghua Zheng1, Junjie Wei, Yulan Tang, Chengcheng Yang, Yunfei Wei, Xiaoduan Yin, Qianqian Liu.   

Abstract

Disruption of the blood-brain barrier (BBB) is a surrogate marker of acute inflammatory lesions in multiple sclerosis (MS) and its animal model experimental autoimmune encephalomyelitis (EAE). Data from experiments suggest that apolipoprotein E (ApoE) plays an important role in the antiinflammatory and immunological process in MS/EAE. Recent researches have shown that lack of ApoE leads to loss of cerebrovascular integrity and BBB breakdown causing neuronal injury. Cerebrovascular effects of ApoE might be another important element resulting to more susceptibility to MS/EAE. However, there is no direct evidence that ApoE dependently contributes to maintaining BBB integrity in EAE. In this study, we induced EAE in ApoE-/- mice and wild-type mice. During EAE, our results show that lack of ApoE increased the Evan's blue (EB) permeability of BBB. Furthermore, deficiency of ApoE upregulated MMP-9 expression activity but decreased the expression of endothelial cell tight junction integral proteins claudin-5 and occludin. Our result also suggests that the protective role of ApoE in EAE by maintaining BBB integrity could be another interesting therapeutic target at MS/EAE.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24788224     DOI: 10.1007/s12031-014-0291-x

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  41 in total

Review 1.  Disruption of central nervous system barriers in multiple sclerosis.

Authors:  Jorge Ivan Alvarez; Romain Cayrol; Alexandre Prat
Journal:  Biochim Biophys Acta       Date:  2010-07-07

2.  ApoE deficiency leads to a progressive age-dependent blood-brain barrier leakage.

Authors:  Ali Hafezi-Moghadam; Kennard L Thomas; Denisa D Wagner
Journal:  Am J Physiol Cell Physiol       Date:  2006-07-26       Impact factor: 4.249

3.  Prevention and treatment of experimental autoimmune encephalomyelitis with clonotypic CDR3 peptides: CD4(+) Foxp3(+) T-regulatory cells suppress interleukin-2-dependent expansion of myelin basic protein-specific T cells.

Authors:  Abigail C Buenafe; Shayne Andrew; Michael Afentoulis; Halina Offner; Arthur A Vandenbark
Journal:  Immunology       Date:  2010-01-06       Impact factor: 7.397

Review 4.  Matrix metalloproteinase-9/gelatinase B is a putative therapeutic target of chronic obstructive pulmonary disease and multiple sclerosis.

Authors:  M E Muroski; M D Roycik; R G Newcomer; P E Van den Steen; G Opdenakker; H R Monroe; Z J Sahab; Q-X Sang
Journal:  Curr Pharm Biotechnol       Date:  2008-02       Impact factor: 2.837

Review 5.  Tissue plasminogen activator (tPA) and matrix metalloproteinases in the pathogenesis of stroke: therapeutic strategies.

Authors:  Rao Muralikrishna Adibhatla; James F Hatcher
Journal:  CNS Neurol Disord Drug Targets       Date:  2008-06       Impact factor: 4.388

6.  Key metalloproteinases are expressed by specific cell types in experimental autoimmune encephalomyelitis.

Authors:  Henrik Toft-Hansen; Robert K Nuttall; Dylan R Edwards; Trevor Owens
Journal:  J Immunol       Date:  2004-10-15       Impact factor: 5.422

7.  Blood-brain barrier alterations in the cerebral cortex in experimental autoimmune encephalomyelitis.

Authors:  Mariella Errede; Francesco Girolamo; Giovanni Ferrara; Maurizio Strippoli; Sara Morando; Valentina Boldrin; Marco Rizzi; Antonio Uccelli; Roberto Perris; Caterina Bendotti; Mario Salmona; Luisa Roncali; Daniela Virgintino
Journal:  J Neuropathol Exp Neurol       Date:  2012-10       Impact factor: 3.685

8.  Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells.

Authors:  A S Plump; J D Smith; T Hayek; K Aalto-Setälä; A Walsh; J G Verstuyft; E M Rubin; J L Breslow
Journal:  Cell       Date:  1992-10-16       Impact factor: 41.582

Review 9.  Regulation of immune cell infiltration into the CNS by regional neural inputs explained by the gate theory.

Authors:  Yasunobu Arima; Daisuke Kamimura; Lavannya Sabharwal; Moe Yamada; Hidenori Bando; Hideki Ogura; Toru Atsumi; Masaaki Murakami
Journal:  Mediators Inflamm       Date:  2013-08-06       Impact factor: 4.711

Review 10.  Mmp-9 inhibition: a therapeutic strategy in ischemic stroke.

Authors:  Mayank Chaturvedi; Leszek Kaczmarek
Journal:  Mol Neurobiol       Date:  2013-09-12       Impact factor: 5.590

View more
  15 in total

Review 1.  Dual roles of astrocytes in plasticity and reconstruction after traumatic brain injury.

Authors:  Yunxiang Zhou; Anwen Shao; Yihan Yao; Sheng Tu; Yongchuan Deng; Jianmin Zhang
Journal:  Cell Commun Signal       Date:  2020-04-15       Impact factor: 5.712

Review 2.  The role of APOE in cerebrovascular dysfunction.

Authors:  Leon M Tai; Riya Thomas; Felecia M Marottoli; Kevin P Koster; Takahisa Kanekiyo; Alan W J Morris; Guojun Bu
Journal:  Acta Neuropathol       Date:  2016-02-16       Impact factor: 17.088

3.  Exposure to traffic-generated air pollution promotes alterations in the integrity of the brain microvasculature and inflammation in female ApoE-/- mice.

Authors:  Anna Adivi; JoAnn Lucero; Nicholas Simpson; Jacob D McDonald; Amie K Lund
Journal:  Toxicol Lett       Date:  2020-12-26       Impact factor: 4.372

4.  Bexarotene reduces blood-brain barrier permeability in cerebral ischemia-reperfusion injured rats.

Authors:  Lu Xu; Fang Cao; Feng Xu; Baicheng He; Zhi Dong
Journal:  PLoS One       Date:  2015-04-06       Impact factor: 3.240

5.  Gas6 Promotes Oligodendrogenesis and Myelination in the Adult Central Nervous System and After Lysolecithin-Induced Demyelination.

Authors:  Salman Goudarzi; Andrea Rivera; Arthur M Butt; Sassan Hafizi
Journal:  ASN Neuro       Date:  2016-09-14       Impact factor: 4.146

6.  Matrix metalloproteinase-9 activity and a downregulated Hedgehog pathway impair blood-brain barrier function in an in vitro model of CNS tuberculosis.

Authors:  Sara Brilha; Catherine W M Ong; Babette Weksler; Nacho Romero; Pierre-Olivier Couraud; Jon S Friedland
Journal:  Sci Rep       Date:  2017-11-22       Impact factor: 4.379

7.  Hydrogen sulfide protects against the development of experimental cerebral malaria in a C57BL/6 mouse model.

Authors:  Ping Jiang; Zhishen Xu; Baiquan Xiao; Zhong Han; Jiehong Huang; Jianbang Xu; Zhaorong Lun; Wenliang Zhou
Journal:  Mol Med Rep       Date:  2017-06-23       Impact factor: 2.952

8.  ApoE Influences the Blood-Brain Barrier Through the NF-κB/MMP-9 Pathway After Traumatic Brain Injury.

Authors:  Zhipeng Teng; Zongduo Guo; Jianjun Zhong; Chongjie Cheng; Zhijian Huang; Yue Wu; Shuang Tang; Chao Luo; Xing Peng; Haitao Wu; Xiaochuan Sun; Li Jiang
Journal:  Sci Rep       Date:  2017-07-27       Impact factor: 4.379

9.  Expression profiles of cholesterol metabolism-related genes are altered during development of experimental autoimmune encephalomyelitis in the rat spinal cord.

Authors:  Irena Lavrnja; Kosara Smiljanic; Danijela Savic; Aleksandra Mladenovic-Djordjevic; Katarina Tesovic; Selma Kanazir; Sanja Pekovic
Journal:  Sci Rep       Date:  2017-06-02       Impact factor: 4.379

10.  Potential implications of Apolipoprotein E in early brain injury after experimental subarachnoid hemorrhage: Involvement in the modulation of blood-brain barrier integrity.

Authors:  Jinwei Pang; Yue Wu; Jianhua Peng; Ping Yang; Li Kuai; Xinghu Qin; Fang Cao; Xiaochuan Sun; Ligang Chen; Michael P Vitek; Yong Jiang
Journal:  Oncotarget       Date:  2016-08-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.